A <i><u>R</u></i>andomis <i><u>e</u></i>d Control Trial of <i><u>S</u></i>tatin and Asp <i><u>i</u></i>rin as Adjuvant Therapy in Patients with <i><u>S</u></i>ARS-CoV-2 Infec <i><u>ti</u></i>on (RESIST Trial)
SSRN Electronic Journal (2021) - Comments
doi: 10.2139/ssrn.3820512  issn: 1556-5068 

Nirmal Ghati, Siddharthan Deepti, Sushma Bhatnagar, Manjit Mahendran, Abhishek Thakur, Kshitij Prasad, Devesh Kumar, Tanima Dwivedi, Kalaivani Mani, Pawan Tiwari, Ritu Gupta, Anant Mohan, Anita Saxena, Randeep Guleria, Ambuj Roy